Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
As attached23-06-2021
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of Notice in connection with Extra-ordinary General Meeting of the Company published today i.e. 17th June, 2021 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers.17-06-2021
MARKSANS PHARMA LTD. - 524404 - Clarification sought from Marksans Pharma Ltd
The Exchange has sought clarification from Marksans Pharma Ltd on June 17, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.17-06-2021
Marksans Pharma Ltd - 524404 - Notice Of The Extra-Ordinary General Meeting (EGM) Of The Company
This is to inform you that the Extra-Ordinary General Meeting("EGM") of Marksans Pharma Limited ('the Company') is scheduled to be held on Friday, July 09, 2021 at 09:00 A.M through Video Conferencing/Other Audio Visual Means (VC) in terms of the relevant circulars issued by Ministry of Corporate Affairs and the Securities Exchange Board of India. The copy of the Notice of EGM along with instructions for e-voting is enclosed herewith for your kind reference. The Notice of EGM is being sent by email to all the members whose email IDs are registered with the Company / the Depositories. The EGM Notice is also being made available on the website of the Company at www.marksanspharma.com.16-06-2021
MARKSANS PHARMA LTD. - 524404 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the details of loss of share certificate and request for issue of duplicate share certificate reported by one shareholder of our Company, received from our Registrar and Transfer Agent, Bigshare Services Private Limited on June 15, 2021.15-06-2021
MARKSANS PHARMA LTD. - 524404 - Board Meeting Intimation for Notice Of Board Meeting
MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/06/2021 ,inter alia, to consider and approve issuance of convertible warrants on preferential basis.10-06-2021